Paracelsus Medical University Salzburg initiates new research collaboration with Boehringer Ingelheim to investigate the natural regenerative potential of extracellular vesicles derived from human stem cells of the supporting tissue. The application of these vesicles will be studied in musculoskeletal or central nervous system disorders.
For over six years, the PMU has been conducting a research program called “Nanovesicular Therapies” in collaboration with university hospitals and the Paris-Lodron University Salzburg. We have previously reported on this.
The director of the Institute of Experimental Neuroregeneration at PMU Salzburg, Sébastien Couillard-Després, views the collaboration with Boehringer Ingelheim as a “visionary cooperation program that enables the development of innovative approaches for treating complex disorders of the central nervous system and musculoskeletal tissue at PMU.”
Further links
To the article
This might also interest you
8. March 2024
How do we shape our future?
Political and technological challenges, as well as solutions to questions about the world of tomorrow, were discussed at the well-attended Innovation and Technology Forum salz21 on March 6th at the Salzburg Exhibition Center. Let’s take a look back at the panels organized by Innovation Salzburg.
17. January 2024
Research premium – this is how you apply!
SMEs can apply to the tax office for a research premium for expenditure on research and development (R&D). We show you how it works!
13. October 2023
Circular Economy:
Building with and in Existing Structures
“Dismantle. Breakthrough. Departure.” was the motto of this year’s Alpine Construction Symposium at the Salzburg University of Applied Sciences on October 12, 2023. The focus was on topics related to construction in existing structures and the recycling of materials from decommissioned buildings. There are many challenges in this regard, but also solutions.
18. September 2023
At the Interface Between Human and Computer: The New III.Lab in Salzburg
The triple I in the lab name stands for “Intelligent Interfaces Innovation,” describing research at the intersection of humans and technologies. The lab was inaugurated on September 15, 2023, and is available for collaborations with companies, emphasizing planned application-oriented research.